Botulinum toxin in treatment of clubfoot relapse

Details for Australian Patent Application No. 2006283638 (hide)

Owner Allergan, Inc.

Inventors Alvarez, Christine M.

Agent Davies Collison Cave

Pub. Number AU-B-2006283638

PCT Pub. Number WO2007/024630

Priority 60/709,451 19.08.05 US

Filing date 16 August 2006

Wipo publication date 1 March 2007

Acceptance publication date 2 February 2012

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2007/024630 Priority application(s): WO2007/024630

2 February 2012 Application Accepted

  Published as AU-B-2006283638

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283641-Multi-directional immunochromatographic assays

2006283634-Distributed single sign-on service